Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
1,451 people get ASTM articles and Market Currents by email alert.
Get email alerts on ASTM »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
GlobeNewswire (May 8, 2013)
-
GlobeNewswire (May 3, 2013)
-
-
-
GlobeNewswire (Apr 25, 2013)
-
GlobeNewswire (Apr 19, 2013)
-
-
-
GlobeNewswire (Apr 9, 2013)
-
GlobeNewswire (Apr 4, 2013)
-
-
-
GlobeNewswire (Mar 18, 2013)
-
-
GlobeNewswire (Mar 12, 2013)
-
GlobeNewswire (Mar 6, 2013)
-
-
-
-
-
-
-
-
-
-
Aastrom Biosciences Q3/11 Earnings ResultsHenry McCusker • Wed, Nov 9, 2011
-
-
Aastrom Biosciences' Trial Meets Safety and Efficacy EndpointsM. E. Garza • Thu, Jun 2, 2011
-
-
-
-
-
-
-
-
-
Talking With Aastrom Biosciences Execs: Previewing Clinical Trial InfoM. E. Garza • Mon, Nov 15, 2010
-
Aastrom Biosciences, Inc. Q2 2008 Earnings Call TranscriptFri, Feb 8, 2008
-
GlobeNewswire (May 8, 2013)
-
GlobeNewswire (May 3, 2013)
-
GlobeNewswire (Apr 25, 2013)
-
GlobeNewswire (Apr 19, 2013)
-
GlobeNewswire (Apr 9, 2013)
-
GlobeNewswire (Apr 4, 2013)
-
GlobeNewswire (Mar 18, 2013)
-
GlobeNewswire (Mar 12, 2013)
-
GlobeNewswire (Mar 6, 2013)
-
at MarketWatch.com (Jan 2, 2013)
-
GlobeNewswire (Dec 12, 2012)
-
GlobeNewswire (Dec 10, 2012)
-
GlobeNewswire (Nov 26, 2012)
-
GlobeNewswire (Nov 20, 2012)
-
GlobeNewswire (Nov 8, 2012)
-
GlobeNewswire (Nov 5, 2012)
-
GlobeNewswire (Oct 29, 2012)
-
GlobeNewswire (Oct 4, 2012)
-
GlobeNewswire (Sep 19, 2012)
ASTM vs. ETF Alternatives
Company Description
We are a regenerative medicine company (a medical area that focuses on developing therapies that regenerate damaged or diseased tissues or organs) that incorporated in 1989 and focuses on the clinical development of autologous cell products (cells collected from a patient and returned to that... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, May 9, 11:15 AM Aastrom Biosciences (ASTM -4.1%) slips today despite posting a Q1 net loss of -$0.15, which was narrower than the prior year and beat analysts estimates for a loss of $0.19 per share. The company also reported cash guidance, saying that it had a total of $9.2M in cash and cash equivalents, compared to $13.6 million in cash and cash equivalents in December. The cash used for operations during Q1 came to $6.8M. Comment! [Healthcare, On the Move, Earnings]
- Wednesday, May 8, 6:50 PM Aastrom (ASTM): Q1 EPS of -$0.15 beats by $0.04. Revenue of $8K. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Tuesday, March 19, 2:52 PM Aastrom Biosciences (ASTM -7.8%) trades near its 52-week low today, after the company reported bigger Q4 losses Y/Y in yesterday's after hours session. Bottom line margins were hit hard by heavy SG&A charges for non-cash stock based compenstation, plus higher overall R&D costs. 1 Comment [Healthcare, On the Move, Earnings]
- Monday, March 18, 5:20 PM More on Aastrom Biosciences (ASTM): Q4 beats but losses more than double Y/Y, primarily due to charges and an increases in R&D expenses. Comment! [Healthcare, Earnings]
- Monday, March 18, 4:13 PM Aastrom (ASTM): Q4 EPS of -$0.18 beats by $0.05. (PR) Comment! [Earnings, Breaking News, Healthcare]
-
- View all 0 replies
-
- View all 1 replies
-
FortSumter: I saw somewhere you mentioned $TTS. Do you have a current opinion? I like the analogy to $LL. Not much out there for dd.
-
- View all 0 replies
-
Joshua Hayes
Big Wave Trading Portfolio Update And Top Current Holdings http://bit.ly/WIktXd $KBE $XHB $VRNM $ASTM $CSU $CAMP $NTE - View all 0 replies
-
- View all 0 replies
-
Michael Bryant
Neptune Technologies and Bioresources (NEPT), Aastrom Biosciences (ASTM), and Celsion (CLSN) look good. http://bit.ly/pJesA4 - View all 0 replies
-
- View all 0 replies
-
AAstromMan
Monday WIll ASTM be mentioned? Feb 07, 2011 Monday 9 PM National geographic http://on.natgeo.com/ihm9db - View all 0 replies
-
AAstromMan
http://bit.ly/hmznPA Billy amer story .. AM RADIO, DR. AMIT PATEL AND STEM CELLS ( ASTM ) saved my life - View all 0 replies
-
- View all 0 replies
LATEST REPLIES
-
- View all 1 replies
-
FortSumter: I saw somewhere you mentioned $TTS. Do you have a current opinion? I like the analogy to $LL. Not much out there for dd.